Suzuki, Y., Kohno, K., Matsue, K., Sakakibara, A., Ishikawa, E., Shimada, S., . . . Satou, A. PD‐L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B‐cell lymphoma treated with rituximab‐based multi‐agent chemotherapy. Wiley.
Chicago Style (17th ed.) CitationSuzuki, Yuka, et al. PD‐L1 (SP142) Expression in Neoplastic Cells Predicts a Poor Prognosis for Patients with Intravascular Large B‐cell Lymphoma Treated with Rituximab‐based Multi‐agent Chemotherapy. Wiley.
MLA (9th ed.) CitationSuzuki, Yuka, et al. PD‐L1 (SP142) Expression in Neoplastic Cells Predicts a Poor Prognosis for Patients with Intravascular Large B‐cell Lymphoma Treated with Rituximab‐based Multi‐agent Chemotherapy. Wiley.
Warning: These citations may not always be 100% accurate.